Metropolis to Quadruple Genomics Test Menu to 500 in Two Years

• Metropolis Healthcare plans to expand its genomics test menu from 220 to 500 tests over the next two years.
• Genomics tests are crucial for diagnosing cancer, stroke, immune disorders, and rare genetic conditions, enabling faster and more accurate treatment.
• The company has launched a Centre for Genomics to enhance specialty testing and advanced diagnostics in India, combining testing with genetic counseling and bioinformatics.
• Metropolis aims for 13-15% organic growth in FY26-FY27 and expects genomics to support margin expansion.
• Metropolis is also expanding basic radiology services and evaluating entry into CT scans and MRI services, while focusing on internal capability building for genomics.

Why It Matters: Metropolis Healthcare is aggressively expanding its genomics testing capabilities and advanced diagnostics in India.